Business
Currency:USD
2023/FY
Stock NameRevenueRatio
Venous Thromboembolism (VTE)476.28M96.48%
Emerging Therapies17.36M3.52%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States469.86M95.19%
International23.77M4.81%